UPM Raflatac to showcase extended range of pharmaceutical security labeling solutions at Pharmapack 2019, ParisPress Release 28.1.2019 11:00 EET
(UPM Raflatac, Helsinki, 28 January 2019 at 11:00 EET) - UPM Raflatac will showcase its comprehensive range of security labeling solutions for pharmaceutical and healthcare packaging at the Pharmapack 2019 event in Paris, held on February 6-7, 2019. Among other solutions, the range includes a reliable new solution for presence verification of tamper-evident labels on cartons, offering 100% accuracy regardless of packaging color or design.
The UPM Raflatac pharmaceutical security label materials are designed to improve patient safety through tamper-evident solutions, offering an easy route to achieving full compliance with the upcoming EU Falsified Medicines Directive (2011/62/EU) in time for the February 9, 2019 deadline.
UPM Raflatac's solutions work with pharmaceutical adhesive RP62 EU to offer a range of tamper-verification safety features that lead to visible, irreversible damage or change to the packaging or label when removed: clear labels that tear cardboard packaging, void-effect labels that permanently reveal a hidden pattern or text, and fragile seal-label products that become irreversibly torn or broken.
Visitors to Pharmapack can learn more about UPM Raflatac's solutions for pharmaceutical and healthcare labeling at stand D22 in hall 1.
For further information please contact:
Markku Pietarinen, Manager, Business Segments & Pharma, Specials EMEIA, tel. + 358 405 434658
UPM, Media Relations
Mon-Fri 9:00-16:00 EET
tel. +358 40 588 3284
UPM Raflatac is labeling a smarter future by developing innovative and sustainable labeling solutions complemented with world-class service. As one of the world's leading producers of self-adhesive label materials, we supply high-quality paper and film label stock for consumer product and industrial labeling through a global network of factories, distribution terminals and sales offices. We employ around 3,000 people and made sales of EUR 1.5 billion (USD 1.9 billion) in 2017. UPM Raflatac is part of UPM - The Biofore Company. Find out more at www.upmraflatac.com.
We deliver renewable and responsible solutions and innovate for a future beyond fossils across six business areas: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Specialty Papers, UPM Communication Papers and UPM Plywood. We employ around 19,100 people worldwide and our annual sales are approximately EUR 10 billion. Our shares are listed on NASDAQ OMX Helsinki. UPM Biofore - Beyond fossils. www.upm.com